Clinical Trials Browser

Phase NA × Active not recruiting × Magnetic Resonance Spectroscopy × Clear all

NCT02615275 2026-04-16

Bioelectrical Impedance Analysis in Estimating Body Composition in Patients With Stage I-IV Head and Neck Cancer Undergoing Radiation Therapy

Phase NA Active not recruiting

Head and Neck Carcinoma

NCT03965481 2026-04-15

PET/MR Versus CECT Scans in Imaging Patients With Ovarian Cancer or Highly Suspected Ovarian Cancer

Phase NA Active not recruiting

Ovarian Neoplasms

NCT05055843 2026-04-15

Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Screening Prostate Cancer

Phase NA Active not recruiting

Prostatic Neoplasms

NCT02194738 2026-04-13

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

Phase NA Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06421142 2026-04-13

FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder Cancer

Phase NA Active not recruiting

Urinary Bladder Neoplasms

NCT02722525 2026-03-23

Cardiac MRI in Measuring the Impact of Anti-androgen Treatment on Cardiac Function in Patients With Prostate Cancer

Phase NA Active not recruiting

Prostatic Neoplasms

NCT04239573 2026-03-23

Comparing Two Methods to Follow Patients With Pancreatic Cysts

Phase NA Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT03968315 2026-03-09

An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma

Phase NA Active not recruiting

Thymoma

NCT03085043 2026-03-05

Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate Cancer

Phase NA Active not recruiting

Prostatic Neoplasms

NCT05823740 2026-02-20

Measuring Changes in Body Composition and Physical Function in Patients With Childhood Cancers

Phase NA Active not recruiting

Neoplasms

NCT02226276 2026-02-13

Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer

Phase NA Active not recruiting

10 enrolled 8 charts

Breast Neoplasms

NCT04251481 2026-01-22

Diffusion MRI for Head and Neck Cancer

Phase NA Active not recruiting

Head and Neck Neoplasms

NCT01266096 2025-12-31

PET Imaging of Patients With Melanoma and Malignant Brain Tumors Using an 124I-labeled cRGDY Silica Nanomolecular Particle Tracer: A Microdosing Study

Phase NA Active not recruiting

Melanoma

NCT02352883 2025-12-19

MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ

Phase NA Active not recruiting

Carcinoma, Intraductal, Noninfiltrating

NCT01737619 2025-11-28

PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer

Phase NA Active not recruiting

101 enrolled 8 charts

Mixed Tumor, Mesodermal

NCT06132087 2025-11-25

PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy

Phase NA Active not recruiting

Gastrointestinal

Locally Advanced Pancreatic Adenocarcinoma

NCT04888988 2025-11-21

CIPN

Phase NA Active not recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT01093612 2025-11-14

Positron Emission Tomography in Women With Advanced HER2-Positive Breast Cancer

Phase NA Active not recruiting

18 enrolled 6 charts

Breast Neoplasms

NCT02293954 2025-11-14

Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer

Phase NA Active not recruiting

20 enrolled 8 charts

BreastGastrointestinalThoracic

Bile Duct Neoplasms, Breast Neoplasms, Colonic Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Rectal Neoplasms, Carcinoma, Medullary

NCT03196518 2025-06-05

Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer

Phase NA Active not recruiting

Thyroid Neoplasms

NCT05830838 2025-05-21

DAPPER

Phase NA Active not recruiting

Prostatic Neoplasms

NCT01653080 2025-04-11

MRI in Diagnosing Solid Tumors of the Eye and Orbit

Phase NA Active not recruiting

Eye Neoplasms

NCT01653093 2025-04-11

3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer

Phase NA Active not recruiting

Prostatic Neoplasms

NCT03303846 2025-04-11

Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients

Phase NA Active not recruiting

Healthy Subject